More than two years after the Jumpstart Our Business Startups (JOBS) Act was signed into law, Title III of the act, which allows for equity-based crowdfunding from non-accredited investors, still hasn't been implemented by the SEC. Read More
The Jumpstart Our Business Startups (JOBS) Act has had an extremely positive influence on the growth prospects for emerging biotechnology companies since it came into being in 2012. In fact, there has been a tidal wave of companies who have successfully completed their initial public offerings (IPOs) since its introduction. Read More